Today, Oticon Medical is pleased to share that Demant has successfully finalized the agreement with Impilo, transferring ownership of Oticon Medical to Impilo and marking the beginning of a new strategic chapter for the organization.
The acquisition positions Oticon Medical to further accelerate innovation, strengthen its market presence, and continue delivering life changing bone anchored hearing solutions (BAHS) to patients worldwide.
The agreement includes a long-term collaboration between Oticon Medical, Impilo, and Demant, ensuring continuity and advancing joint development of next generation Ponto and Sentio sound processors, alongside continued manufacturing, and supply partnerships.
For customers, partners, and patients, the transition brings full operational continuity—daily operations, local sales structures, and customer support remain unchanged.
“Impilo shares our values and vision, and as our new owner, brings the investment and strategic focus needed to further strengthen our position in the BAHS market,” says René Govaerts, President & General Manager, Oticon Medical. “We are confident this partnership will help us continue delivering exceptional solutions and support.”
“We are delighted to partner with management on the acquisition of Oticon Medical to accelerate growth, drive innovation, and further improve patient outcomes. The company has established itself as a leading player in the attractive and underpenetrated global BAHS market and has strengthened its position with the recently launched transcutaneous product, Sentio, which has already demonstrated impressive results. We are deeply impressed by the management team’s expertise, their ability to deliver outstanding patient support, and their unwavering commitment to improving patient outcomes. We look forward to our partnership with management and to the journey ahead, advancing the development of cutting-edge BAHS solutions that will further enhance the lives of patients.” says Magnus Edlund, Partner at Impilo.
Oticon Medical remains dedicated to delivering solutions that elevate hearing and enrich lives. With a clear vision ahead and the support of its new owner, the company is poised to advance boldly into the next era of growth and innovation.
About Oticon Medical
Oticon Medical is a global company in implantable hearing solutions, dedicated to bringing the power of sound to people at every stage of life. For more than a decade, we have made bone anchored hearing systems more accessible by simplifying the treatment for physicians, audiologists, and patients alike.
We believe that patients and hearing care professionals should be able to choose the best possible solution at any time along the patient journey. We call it “Freedom of Choice” and it has always been paramount to Oticon Medical. This is the reason why our solutions are designed to be compatible whenever possible. As a result, an implant from Oticon Medical stands as a true testament to our unwavering lifelong support.
We work collaboratively with professionals to ensure that every solution we create is designed with our users’ needs in mind. We have a strong passion to provide innovative solutions and support that enhance quality of life and help people live life to the fullest – now and in the future.
Because we know how much sound matters.
About Impilo
Impilo is a Nordic investment company focused solely on investments in lower-mid-market Nordic healthcare companies. It seeks majority buyouts of privately held companies across the pharmaceuticals, MedTech, specialist pharma services and other healthcare & related services industries. Target companies must contribute to the positive and sustainable development of the markets in which they operate, as well as have a credible path to becoming a market leader in their respective niche. Impilo has a well-diversified portfolio of healthcare investments and manages approximately €2 billion of capital from leading international investors.